Surviving sepsis campaign: research priorities for sepsis and septic shock.

Surviving sepsis campaign: research priorities for sepsis and septic shock.
复制标题

幸存的败血症运动:败血症和败血性冲击的研究重点。

DOI:
10.1007/s00134-018-5175-z
复制
发表时间:
2018-09
影响因子:
38.9
通讯作者:
Rhodes A
Rhodes A
中科院分区:
医学1区
文献类型:
--
作者:
Coopersmith CM;De Backer D;Deutschman CS;Ferrer R;Lat I;Machado FR;Martin GS;Martin-Loeches I;Nunnally ME;Antonelli M;Evans LE;Hellman J;Jog S;Kesecioglu J;Levy MM;Rhodes A

文献摘要

参考文献

被引文献

相似文献

确定脓毒症和脓毒性休克的管理、流行病学、结局和根本原因方面的研究重点。一个由代表欧洲重症监护医学学会和重症监护医学学会的16名国际专家组成的共识委员会在两个学会的年会上召开。分组举行了电话会议和电子讨论。整个委员会反复制定了整个文件和建议。每个委员会成员独立地给出了他们对脓毒症研究的五大优先事项。委员会共同主席将总共88条建议(ESM 1 -补充表1)分为7个亚组:感染、液体和血管活性药物、抗感染治疗、给药/流行病学、评分/鉴定、重症监护病房后和基础/转化科学。每个分组都举行了电话会议,讨论每个优先事项,然后在每个分组内进行正式投票。整个委员会还对除基础/转化科学外的所有分组的优先事项进行了投票。败血症生存研究委员会为败血症和败血性休克提供了26个优先事项。其中,确定了六个最重要的临床优先事项,包括以下问题:(1)靶向/个性化/精确医学方法能否确定哪些疗法在哪些时间对哪些患者有效?(2)容量复苏的理想终点是什么?容量复苏应如何滴定?(3)临床实践中是否应该实施快速诊断试验?(4)经验性抗生素联合治疗是否应用于脓毒症或脓毒性休克?(5)脓毒症长期发病率和死亡率的预测因素是什么?(6)哪些信息可以识别器官功能障碍?虽然败血症生存运动指南对败血症的治疗提出了多项建议,但在直接适用于临床医生的床边问题以及理解败血症发展和进展的基本机制方面仍然存在重大的知识差距。确定的优先事项代表了脓毒症和脓毒性休克研究的路线图。本文的在线版本(10.1007/s 00134 -018-5175-z)包含补充材料,可供授权用户使用。
To identify research priorities in the management, epidemiology, outcome and underlying causes of sepsis and septic shock. A consensus committee of 16 international experts representing the European Society of Intensive Care Medicine and Society of Critical Care Medicine was convened at the annual meetings of both societies. Subgroups had teleconference and electronic-based discussion. The entire committee iteratively developed the entire document and recommendations. Each committee member independently gave their top five priorities for sepsis research. A total of 88 suggestions (ESM 1 - supplemental table 1) were grouped into categories by the committee co-chairs, leading to the formation of seven subgroups: infection, fluids and vasoactive agents, adjunctive therapy, administration/epidemiology, scoring/identification, post-intensive care unit, and basic/translational science. Each subgroup had teleconferences to go over each priority followed by formal voting within each subgroup. The entire committee also voted on top priorities across all subgroups except for basic/translational science. The Surviving Sepsis Research Committee provides 26 priorities for sepsis and septic shock. Of these, the top six clinical priorities were identified and include the following questions: (1) can targeted/personalized/precision medicine approaches determine which therapies will work for which patients at which times?; (2) what are ideal endpoints for volume resuscitation and how should volume resuscitation be titrated?; (3) should rapid diagnostic tests be implemented in clinical practice?; (4) should empiric antibiotic combination therapy be used in sepsis or septic shock?; (5) what are the predictors of sepsis long-term morbidity and mortality?; and (6) what information identifies organ dysfunction? While the Surviving Sepsis Campaign guidelines give multiple recommendations on the treatment of sepsis, significant knowledge gaps remain, both in bedside issues directly applicable to clinicians, as well as understanding the fundamental mechanisms underlying the development and progression of sepsis. The priorities identified represent a roadmap for research in sepsis and septic shock. The online version of this article (10.1007/s00134-018-5175-z) contains supplementary material, which is available to authorized users.
DOI: 10.1001/jama.2011.1829
发表时间: 2011-12-21
影响因子: 120.7
作者:
Boomer, Jonathan S.;To, Kathleen;Chang, Kathy C.;Takasu, Osamu;Osborne, Dale F.;Walton, Andrew H.;Bricker, Traci L.;Jarman, Stephen D., II;Kreisel, Daniel;Krupnick, Alexander S.;Srivastava, Anil;Swanson, Paul E.;Green, Jonathan M.;Hotchkiss, Richard S.
通讯作者: Hotchkiss, Richard S.
DOI: 10.1001/jama.2012.5833
发表时间: 2012-06-13
影响因子: 120.7
作者:
Brunkhorst, Frank M.;Oppert, Michael;Welte, Tobias
通讯作者: Welte, Tobias
DOI: 10.1152/ajpregu.00432.2003
发表时间: 2004-03-01
影响因子: 2.8
作者:
Brealey, D;Karyampudi, S;Singer, M
通讯作者: Singer, M
DOI: 10.1093/ageing/afu163
发表时间: 2015-05-01
期刊: AGE AND AGEING
影响因子: 6.7
作者:
Ahasic, Amy M.;Van Ness, Peter H.;Pisani, Margaret A.
通讯作者: Pisani, Margaret A.
DOI: 10.1016/j.immuni.2014.02.009
发表时间: 2014-03-20
期刊: IMMUNITY
影响因子: 32.4
作者:
Buckley, Christopher D.;Gilroy, Derek W.;Serhan, Charles N.
通讯作者: Serhan, Charles N.